Table 2. Composition and Physicochemical Characteristics of NAR-PLGA-NPs.

formulation	particle size (nm)	PDI	zeta potential (mV)	EE (%)	drug dissolution (%)
FN1	492.8 ± 2.71	0.512 ± 0.001	–10.14 ± 0.12	32 ± 4.19	56.50 ± 4.62
FN2	504.8 ± 1.10	0.029 ± 0.003	–10.26 ± 0.07	34 ± 4.38	56.80 ± 4.62
FN3	301.5 ± 0.96	0.028 ± 0.003	–10.7 ± 0.45	40 ± 3.57	61.62 ± 2.82
FN4	179.7 ± 2.05	0.206 ± 0.001	–9.18 ± 0.78	74 ± 3.61	82.11 ± 3.65
FN5	248.4 ± 3.40	0.322 ± 0.002	–11.6 ± 1.65	64 ± 4.20	69.07 ± 4.20
FN6	292.3 ± 1.40	0.287 ± 0.004	–11.4 ± 1.65	42 ± 3.59	56.47 ± 2.98
FN7	265.4 ± 1.91	0.427 ± 0.003	–11.03 ± 0.48	55 ± 4.60	54.11 ± 3.72
FN8	323 ± 2.96	0.581 ± 0.004	–11.0 ± 1.63	40 ± 3.57	56.10 ± 4.62
FN9	283.9 ± 0.80	0.011 ± 0.001	–10.99 ± 0.49	40 ± 3.57	53.07 ± 3.46
FN10	229.7 ± 2.51	0.350 ± 0.005	–9.11 ± 0.78	70 ± 3.58	80.35 ± 3.69